These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 31075872)

  • 1. The Immunomodulatory Properties of Extracellular Vesicles Derived from Probiotics: A Novel Approach for the Management of Gastrointestinal Diseases.
    Molina-Tijeras JA; Gálvez J; Rodríguez-Cabezas ME
    Nutrients; 2019 May; 11(5):. PubMed ID: 31075872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory Effects of Probiotic-Derived Extracellular Vesicles: Opportunities and Challenges.
    Chen X; Li Q; Xie J; Nie S
    J Agric Food Chem; 2024 Sep; 72(35):19259-19273. PubMed ID: 39177683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Horizons in Postbiotics:
    González-Lozano E; García-García J; Gálvez J; Hidalgo-García L; Rodríguez-Nogales A; Rodríguez-Cabezas ME; Sánchez M
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558455
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Extracellular Vesicles Derived From
    Hao H; Zhang X; Tong L; Liu Q; Liang X; Bu Y; Gong P; Liu T; Zhang L; Xia Y; Ai L; Yi H
    Front Immunol; 2021; 12():777147. PubMed ID: 34925349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics.
    Moludi J; Maleki V; Jafari-Vayghyan H; Vaghef-Mehrabany E; Alizadeh M
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):927-939. PubMed ID: 31894861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies.
    Gorreja F; Walker WA
    Gut Microbes; 2022; 14(1):2149214. PubMed ID: 36469568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecules Produced by Probiotics and Intestinal Microorganisms with Immunomodulatory Activity.
    Delgado S; Sánchez B; Margolles A; Ruas-Madiedo P; Ruiz L
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32024101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?
    Villard A; Boursier J; Andriantsitohaina R
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G485-G495. PubMed ID: 33471632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
    de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
    Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?
    Rinaldi E; Consonni A; Guidesi E; Elli M; Mantegazza R; Baggi F
    Ann N Y Acad Sci; 2018 Feb; 1413(1):49-58. PubMed ID: 29341125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gut Microbiota in Celiac Disease and probiotics.
    Chibbar R; Dieleman LA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease.
    Shen Q; Huang Z; Yao J; Jin Y
    J Adv Res; 2022 Mar; 37():221-233. PubMed ID: 35499059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-derived extracellular vesicles in interkingdom communication in the gut.
    Díaz-Garrido N; Badia J; Baldomà L
    J Extracell Vesicles; 2021 Nov; 10(13):e12161. PubMed ID: 34738337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases.
    Plaza-Díaz J; Ruiz-Ojeda FJ; Gil-Campos M; Gil A
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus clausii and gut homeostasis: state of the art and future perspectives.
    Lopetuso LR; Scaldaferri F; Franceschi F; Gasbarrini A
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):943-8. PubMed ID: 27291780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the microbiome in gastrointestinal inflammation.
    Sanders DJ; Inniss S; Sebepos-Rogers G; Rahman FZ; Smith AM
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.
    Samanta S
    Anticancer Agents Med Chem; 2022; 22(4):605-628. PubMed ID: 33305713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics in digestive diseases: focus on Lactobacillus GG.
    Pace F; Pace M; Quartarone G
    Minerva Gastroenterol Dietol; 2015 Dec; 61(4):273-92. PubMed ID: 26657927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.